Angiotensin Peptide Fragments Potentiate SARS-CoV-2 Spike–AXL Receptor Binding: Technical Insights and Implications for Blood Pressure and Viral Pathogenesis Research

Study Background and Research Question

The COVID-19 pandemic, caused by SARS-CoV-2, has spurred intensive investigation into the molecular determinants of viral entry and pathogenesis. While the angiotensin-converting enzyme 2 (ACE2) receptor is recognized as the primary binding site for the viral spike (S) protein, alternative receptors such as AXL and neuropilin-1 (NRP1) have emerged as additional mediators of viral attachment and entry, particularly in tissues with low ACE2 expression. Angiotensin peptides—central mediators in the renin-angiotensin system (RAS) and key regulators of vasoconstriction, aldosterone release, and blood pressure—are produced by enzymatic processing of angiotensinogen via renin and ACE. However, their influence on viral–host interactions has not been fully elucidated. The central question addressed by Oliveira et al. (2025) is whether naturally occurring angiotensin peptide fragments modulate the binding affinity between the SARS-CoV-2 spike protein and its cellular receptors, with a focus on AXL, ACE2, and NRP1 [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067].

Key Innovation from the Reference Study

The study introduces a novel paradigm by demonstrating that discrete angiotensin peptide fragments, including N-terminal truncations such as Angiotensin 1/2 (2-7), markedly enhance the binding of SARS-CoV-2 spike protein to the AXL receptor. This enhancement is not observed with the full-length angiotensin I (1–10) peptide, nor is it universal across all spike–receptor interactions, emphasizing the specificity of fragment length and sequence. The work highlights a previously unrecognized crosstalk between the RAS and viral pathogenesis mechanisms, suggesting that fragments derived from RAS processing can directly modulate viral binding dynamics [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067].

Methods and Experimental Design Insights

Oliveira et al. employed antibody-based binding assays to quantify the interaction between SARS-CoV-2 spike protein and three host receptors: AXL, ACE2, and NRP1. They systematically tested a series of angiotensin peptides, ranging from the full-length angiotensin I (1–10) to various C- and N-terminal truncations, including angiotensin II (1–8), angiotensin (1–7), angiotensin (1–6), angiotensin III (2–8), angiotensin IV (3–8), angiotensin (2–7), and angiotensin (5–7). The impact of specific amino acid substitutions and phosphorylation events on peptide activity was also assessed. The binding enhancement was quantified as a fold-increase relative to baseline, supporting robust comparisons across peptide variants [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067].

Core Findings and Why They Matter

The primary discovery is that certain angiotensin peptide fragments—especially those with N-terminal deletions such as angiotensin III (2–8), angiotensin IV (3–8), and angiotensin (2–7)—produce a pronounced increase (up to 2.7-fold for angiotensin IV) in spike–AXL binding, whereas C-terminal deletions retain, but do not amplify, this effect. Notably, these peptides do not similarly enhance spike–ACE2 or spike–NRP1 interactions, underscoring the selectivity for the AXL receptor [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067]. These findings have several implications:

• Vasoconstrictor peptides such as Angiotensin 1/2 (2-7) may influence viral entry in tissues with low ACE2 but high AXL expression, potentially modulating COVID-19 susceptibility or severity in a tissue-specific manner [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067].
• Post-translational modifications, such as tyrosine substitution or phosphorylation within angiotensin II, further enhance spike–AXL binding, pointing to the importance of specific side-chain interactions for receptor engagement [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067].
• Given the established role of these peptides in blood pressure regulation research and aldosterone release stimulation, the data bridge cardiovascular and infectious disease research domains [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067].

Comparison with Existing Internal Articles

Several internal resources provide additional context for the role of Angiotensin 1/2 (2-7) in both vascular biology and viral pathogenesis. For example, the article "Angiotensin 1/2 (2-7): Emerging Frontiers in Peptide-Driven Blood Pressure and Viral Pathogenesis Research" delves into the peptide’s mechanistic impact on renin-angiotensin signaling and hints at its potential in infectious disease models. The current reference paper advances this by providing direct biochemical evidence of spike–AXL binding enhancement, thus translating mechanistic hypotheses into quantitative assay data. Similarly, "Angiotensin 1/2 (2-7): Advanced Mechanisms and Novel Pathways" contextualizes the peptide’s actions within broader cardiovascular and infection-related signaling, while "Angiotensin 1/2 (2-7): Practical Solutions for Assay Reliability" offers workflow recommendations for optimizing experimental reproducibility with this peptide fragment. The reference study by Oliveira et al. complements these resources by elucidating a concrete molecular mechanism relevant to both research domains.

Limitations and Transferability

While the evidence for enhanced spike–AXL binding is compelling, several limitations should be acknowledged. The study’s findings are based on in vitro binding assays, and the physiological relevance in in vivo infection models remains to be determined. The selectivity of the enhancement effect for the AXL receptor—rather than ACE2 or NRP1—raises questions about tissue-specific and context-dependent impacts. Additionally, while the reference study focuses on naturally processed angiotensin fragments, it does not address potential metabolic or pharmacokinetic alterations in disease states [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067]. Careful experimental design is warranted when translating these findings into complex biological systems.

Why this cross-domain matters, maturity, and limitations

The intersection between renin-angiotensin signaling and viral pathogenesis is of high translational interest. Modulation of spike–AXL interactions by angiotensin fragments such as Angiotensin 1/2 (2-7) may help explain variability in COVID-19 severity among patients with underlying cardiovascular conditions—populations already characterized by altered RAS peptide profiles. However, further studies are needed to establish causality and therapeutic potential, as current evidence is limited to biochemical assays [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067].

Protocol Parameters

• assay | antibody-based spike–receptor binding | concentration range: 0.1–10 μM | suitable for quantifying peptide-mediated modulation of spike–AXL, ACE2, and NRP1 interactions | based on reference study [source_type: paper][source_link: https://doi.org/10.3390/ijms26136067]
• assay | peptide solubility | ≥46.6 mg/mL in water; ≥78.4 mg/mL in DMSO | ensures high-concentration stocks for dose-response studies | product_spec [source_link: https://www.apexbt.com/angiotensin-1-2-2-7.html]
• storage | -20°C | preserves peptide integrity for short-term workflows | product_spec [source_link: https://www.apexbt.com/angiotensin-1-2-2-7.html]
• assay | cell-based viability or cytotoxicity (exploratory) | 1–10 μM | proposed range for initial screens in cardiovascular/viral models | workflow_recommendation

Research Support Resources

To facilitate experimental replication and further mechanistic exploration, researchers can obtain high-purity Angiotensin 1/2 (2-7) peptide (SKU A1050) from APExBIO. This reagent is suitable for both biochemical binding assays and advanced modeling of the renin-angiotensin signaling pathway. For additional workflow guidance and assay optimization tips, consult the relevant internal articles referenced above. All usage should be strictly for research purposes in accordance with supplied specifications.